Skip to content

Evorel Sequi 50mcg/170mcg Transdermal Patches – 8/24 Patches

Evorel Sequi Patches are a prescription-only sequential combined hormone replacement therapy (HRT) containing estradiol (oestrogen) and norethisterone acetate (progestogen). Designed for women experiencing menopause symptoms who still have a womb, Evorel Sequi helps relieve hot flushes, night sweats and other symptoms caused by declining oestrogen levels.

Each pack contains four oestrogen-only patches and four combined oestrogen and progestogen patches, applied twice weekly in a specific sequence over a 28-day treatment cycle.

Price range: £24.00 through £58.00

Clear

Your Health & Wellness Centre

Trusted pharmacy advice, tips and guides for all your healthcare needs

UK Pharmacist Prescribers

Safe & compliant prescribing

GPhC-Approved

UK-Registered Pharmacy

No GP Appointments Needed

Quick, hassle-free online consultation

Secure & Confidential

Your data is 100% protected

Fast & Discreet Delivery

Next-day UK delivery available

NHS Services

NHS Providing Service since 2020

Additional information

Quantity

24 Patches, 8 Patches

Description

Evorel Sequi is a sequential combined hormone replacement therapy designed to relieve symptoms associated with declining oestrogen levels during perimenopause and after menopause.

As women approach menopause, natural oestrogen production gradually decreases. This can cause hot flushes, night sweats, disrupted sleep and other uncomfortable symptoms that affect everyday life.

Evorel Sequi contains two hormones:

  • Estradiol: An oestrogen that replaces declining natural hormone levels and helps relieve menopause symptoms.

  • Norethisterone acetate: A progestogen that helps protect the lining of the womb against excessive thickening caused by oestrogen treatment.

Unlike continuous combined HRT, Evorel Sequi follows a sequential treatment schedule. During the first two weeks, oestrogen-only patches are used. During the following two weeks, patches containing both oestrogen and progestogen are applied.

This treatment is particularly suitable for women who still have a womb and are approaching menopause or have recently become postmenopausal.

The hormones are delivered gradually through the skin, providing a convenient alternative to daily HRT tablets.

Evorel Sequi may also be prescribed to help prevent osteoporosis in selected postmenopausal women at increased risk of fractures when other approved treatments are unsuitable.

Key Benefits

  • Helps relieve hot flushes and night sweats.

  • Replaces declining oestrogen levels during menopause.

  • Contains a progestogen to help protect the womb lining.

  • Suitable for prescribed sequential HRT treatment.

  • Convenient twice-weekly patch changes.

  • Delivers hormones gradually through the skin.

  • Offers an alternative to oral HRT tablets.

  • Designed for women who still have a womb.

  • May help prevent osteoporosis in selected postmenopausal women.

  • Supplied as eight patches for a complete 28-day treatment cycle.

Directions

How to Apply Evorel Sequi Patches

  1. Apply one patch twice weekly, changing it every three to four days.

  2. Choose a clean, dry, hairless area of skin below the waist, preferably the thigh or bottom.

  3. Open the protective sachet immediately before application.

  4. Remove half of the protective backing without touching the adhesive surface.

  5. Apply the exposed adhesive side to the skin.

  6. Remove the remaining backing and press the patch firmly against the skin for at least 10 seconds.

  7. Leave the patch in place until your next scheduled change.

  8. Remove the old patch before applying a new one to a different area.

  9. Follow the correct sequence of oestrogen-only and combined patches.

Example Patch Schedule

Day Action
Monday Apply a new patch
Thursday Replace with the next patch
Following Monday Replace again
Continue Follow the same two days each week

Important Application Advice

  • Never apply the patch on or near the breasts.

  • Avoid cuts, irritated skin and areas beneath tight waistbands.

  • Do not apply moisturiser, cream or talcum powder before application.

  • Do not apply a patch to the same area of skin twice in a row.

  • You can normally shower, bathe and swim while wearing the patch.

  • Keep the patch covered during sunbathing.

  • Do not cut or alter the patch.

Side Effects

Like all medicines, Evorel Sequi may cause side effects, although not everyone experiences them.

Very Common Side Effects

May affect more than 1 in 10 people:

– Redness, itching, irritation or a rash where the patch is applied.

Common Side Effects

May affect up to 1 in 10 people:

  • Headaches.

  • Breast tenderness or pain.

  • Nausea or abdominal discomfort.

  • Irregular vaginal bleeding or spotting.

  • Back pain.

  • Mood changes.

  • Changes in body weight.

Other Possible Side Effects

  • Vaginal infections, including thrush.

  • Reduced sexual desire.

  • Bloating or digestive discomfort.

  • Skin rashes.

  • Swelling of the hands or feet.

  • Muscle pain.

  • Dizziness.

  • Gallstones.

  • Breast enlargement.

Serious Side Effects and Risks

Combined HRT may increase the risk of certain conditions, including breast cancer, blood clots, stroke and heart disease. The risks depend on age, individual medical history and treatment duration.

Seek emergency medical attention if you experience:

  • Sudden chest pain or difficulty breathing.

  • Painful swelling or redness in one leg.

  • Sudden facial weakness, difficulty speaking or other stroke symptoms.

  • Swelling of the face, tongue or throat with breathing difficulties.

Remove the patch and seek urgent medical advice if you develop jaundice, a new migraine-type headache, a significant increase in blood pressure or a severe allergic reaction.

Warnings

Do Not Use Evorel Sequi If You:

  • Have, have previously had or are suspected of having breast cancer.

  • Have a known or suspected oestrogen-dependent cancer.

  • Have unexplained vaginal bleeding.

  • Have untreated endometrial hyperplasia.

  • Have or have previously had a blood clot.

  • Have certain inherited blood-clotting disorders.

  • Have experienced a heart attack, stroke or angina.

  • Have liver disease where liver function has not returned to normal.

  • Have porphyria.

  • Are allergic to estradiol, norethisterone acetate or another ingredient.

Consult Your Doctor Before Treatment If You Have:

  • Uterine fibroids or endometriosis.

  • High blood pressure or diabetes.

  • Migraines or severe headaches.

  • Gallstones or liver problems.

  • Epilepsy or asthma.

  • Heart or kidney conditions.

  • A family history of breast cancer.

  • An increased risk of blood clots.

  • Systemic lupus erythematosus.

  • High triglyceride levels.

  • A history of endometrial hyperplasia.

Additional Safety Information

  • Evorel Sequi is intended for women who still have a womb.

  • It is suitable for certain perimenopausal and postmenopausal women.

  • It is not a contraceptive.

  • Do not use during pregnancy or breastfeeding.

  • Tell your doctor about all medicines and herbal supplements you take, including St John’s wort.

  • Some medicines used for epilepsy, tuberculosis and HIV may affect HRT.

  • Oestrogen treatment may affect lamotrigine and seizure control.

  • Inform your doctor before planned surgery, as HRT may need to be stopped temporarily.

  • Attend regular HRT reviews and recommended breast screening.

  • Report unexpected bleeding that persists beyond six months, begins after six months or continues after stopping treatment.

  • Use the lowest effective dose for the shortest duration consistent with your treatment needs.

Ingredients

Active Ingredients

Each pack contains two types of patches.

Evorel 50 Patches

Each patch contains:

– Estradiol hemihydrate 3.2mg, equivalent to approximately 3.1mg estradiol.

Each patch releases approximately 50 micrograms of estradiol every 24 hours.

Evorel Conti Patches

Each patch contains:

  • Estradiol hemihydrate 3.2mg, equivalent to approximately 3.1mg estradiol.

  • Norethisterone acetate 11.2mg, equivalent to approximately 9.82mg norethisterone.

Each patch releases approximately 50 micrograms of estradiol and 170 micrograms of norethisterone acetate every 24 hours.

Other Ingredients and Patch Materials

  • Acrylic adhesive polymer (Duro-Tak 387-2287).

  • Guar gum.

  • Polyester backing film (Hostaphan MN19).

  • Protective release liner, removed before application.

Storage

  • Do not store above 25°C.

  • Keep patches in their original protective sachets and outer carton.

  • Keep out of the sight and reach of children.

  • Do not use a patch if its protective sachet is already open.

  • Do not use after the expiry date printed on the packaging.

  • Fold used patches in half with the adhesive sides together.

  • Keep used patches away from children and pets.

  • Return unwanted or expired patches to a pharmacy for safe disposal.

Reviews

There are no reviews yet.

Be the first to review “Evorel Sequi 50mcg/170mcg Transdermal Patches – 8/24 Patches”

Your email address will not be published. Required fields are marked *

Verified customer reviews